Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Circulating vitamin D metabolites and kidney disease in type 1 diabetes.

de Boer IH, Sachs MC, Cleary PA, Hoofnagle AN, Lachin JM, Molitch ME, Steffes MW, Sun W, Zinman B, Brunzell JD; Diabetes Control and Complication Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group.

J Clin Endocrinol Metab. 2012 Dec;97(12):4780-8. doi: 10.1210/jc.2012-2852. Epub 2012 Sep 18.

2.
3.

Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study.

Molitch ME, Steffes M, Sun W, Rutledge B, Cleary P, de Boer IH, Zinman B, Lachin J; Epidemiology of Diabetes Interventions and Complications Study Group.

Diabetes Care. 2010 Jul;33(7):1536-43. doi: 10.2337/dc09-1098. Epub 2010 Apr 22.

4.

Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort.

de Boer IH, Rue TC, Cleary PA, Lachin JM, Molitch ME, Steffes MW, Sun W, Zinman B, Brunzell JD; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group, White NH, Danis RP, Davis MD, Hainsworth D, Hubbard LD, Nathan DM.

Arch Intern Med. 2011 Mar 14;171(5):412-20. doi: 10.1001/archinternmed.2011.16.

5.
6.

Estimated GFR and circulating 24,25-dihydroxyvitamin D3 concentration: a participant-level analysis of 5 cohort studies and clinical trials.

de Boer IH, Sachs MC, Chonchol M, Himmelfarb J, Hoofnagle AN, Ix JH, Kremsdorf RA, Lin YS, Mehrotra R, Robinson-Cohen C, Siscovick DS, Steffes MW, Thummel KE, Tracy RP, Wang Z, Kestenbaum B.

Am J Kidney Dis. 2014 Aug;64(2):187-97. doi: 10.1053/j.ajkd.2014.02.015. Epub 2014 Apr 3.

7.

Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes.

DCCT/EDIC Research Group, de Boer IH, Sun W, Cleary PA, Lachin JM, Molitch ME, Steffes MW, Zinman B.

N Engl J Med. 2011 Dec 22;365(25):2366-76. doi: 10.1056/NEJMoa1111732. Epub 2011 Nov 12.

8.

Albuminuria Changes and Cardiovascular and Renal Outcomes in Type 1 Diabetes: The DCCT/EDIC Study.

de Boer IH, Gao X, Cleary PA, Bebu I, Lachin JM, Molitch ME, Orchard T, Paterson AD, Perkins BA, Steffes MW, Zinman B; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group.

Clin J Am Soc Nephrol. 2016 Nov 7;11(11):1969-1977. Epub 2016 Oct 24.

9.

Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study.

Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.

JAMA. 2003 Oct 22;290(16):2159-67.

10.

Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study.

de Boer IH, Sibley SD, Kestenbaum B, Sampson JN, Young B, Cleary PA, Steffes MW, Weiss NS, Brunzell JD; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group.

J Am Soc Nephrol. 2007 Jan;18(1):235-43. Epub 2006 Dec 6.

11.

Circulating vitamin D metabolites and subclinical atherosclerosis in type 1 diabetes.

Sachs MC, Brunzell JD, Cleary PA, Hoofnagle AN, Lachin JM, Molitch ME, Steffes MW, Zinman B, de Boer IH; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group.

Diabetes Care. 2013 Aug;36(8):2423-9. doi: 10.2337/dc12-2020. Epub 2013 Mar 25.

12.

Renal outcomes in patients with type 1 diabetes and macroalbuminuria.

de Boer IH, Afkarian M, Rue TC, Cleary PA, Lachin JM, Molitch ME, Steffes MW, Sun W, Zinman B; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group.

J Am Soc Nephrol. 2014 Oct;25(10):2342-50. doi: 10.1681/ASN.2013091004. Epub 2014 Jun 12.

13.

Sequence of progression of albuminuria and decreased GFR in persons with type 1 diabetes: a cohort study.

Costacou T, Ellis D, Fried L, Orchard TJ.

Am J Kidney Dis. 2007 Nov;50(5):721-32.

PMID:
17954285
14.

Plasma Vitamin D Level and Change in Albuminuria and eGFR According to Sodium Intake.

Keyzer CA, Lambers-Heerspink HJ, Joosten MM, Deetman PE, Gansevoort RT, Navis G, Kema IP, de Zeeuw D, Bakker SJ, de Borst MH; PREVEND Study Group.

Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2119-27. doi: 10.2215/CJN.03830415. Epub 2015 Oct 8.

16.

Vitamin D analogue therapy, cardiovascular risk and kidney function in people with Type 1 diabetes mellitus and diabetic nephropathy: a randomized trial.

Joergensen C, Tarnow L, Goetze JP, Rossing P.

Diabet Med. 2015 Mar;32(3):374-81. doi: 10.1111/dme.12606. Epub 2014 Nov 5.

PMID:
25307511
17.

Serum levels of advanced glycation endproducts and other markers of protein damage in early diabetic nephropathy in type 1 diabetes.

Perkins BA, Rabbani N, Weston A, Ficociello LH, Adaikalakoteswari A, Niewczas M, Warram J, Krolewski AS, Thornalley P.

PLoS One. 2012;7(4):e35655. doi: 10.1371/journal.pone.0035655. Epub 2012 Apr 25.

19.

[Relationship between low glomerular filtration rate, hypertension, and microalbuminuria in type 1 diabetes mellitus].

Vasović O, Zamaklar M, Lalić K, Milosević D, Zikić L, Popović L, Ozegović J, Rajković N, Dragković D.

Vojnosanit Pregl. 2005 May;62(5):349-55. Serbian.

PMID:
15913038
20.

Systematic review on urine albumin testing for early detection of diabetic complications.

Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C.

Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. Review.

Supplemental Content

Support Center